The overall objective of the Cell Function Analysis Core at the University of Washington Diabetes Research Center is to provide affiliates with analyses of glucose metabolism, mitochondrial function and intracellular signaling to support research of diabetes, obesity and related disorders. To achieve this goal, the Core aims to: (1) Provide real time functional analysis using in vitro flow culture systems of tissues/cells; (2) Provide in vivo assessments of metabolic phenotypes in rodent models important in diabetes research; (3) Provide static assessment of cellular metabolism and function; (4) Harvest, isolate and culture primary tissue from rodents, including islets and islet cells, liver, retina and brain, for subsequent morphological and functional characterization, as well as to procure human islets for the same purposes; (5) Offer training and consultation to affiliates, their trainees and staff; and (6) Develop new analytical tools requested by affiliates to support their studies of the metabolic regulation of cell function as it relates to research in diabetes, obesity and related disorders. Since inception of the Core in 2002, in vitro analysis has been the major focus. Cell and tissue types that have been analyzed include islets, retina, skeletal muscle, stem cells, macrophages, lymphocytes, adipocytes, endothelial cells, neuronal cells and liver/hepatocytes. Recently, in vivo services have been added to combine both the detailed and mechanistic analyses provided in cell and tissue studies with the ability to test the roles of identified processes in whole body settings. Whole animal studies currently offered include glucose and insulin tolerance tests, hyperinsulinemic-euglycemic clamps, islet transplantation and collection of lymph. Expansion of new in vitro, ex vivo, and in vivo services has allowed the Core to better serve the needs of the Center's research base. As diabetes affects metabolism and signaling in many cell types, the services of the Cell Function Analysis Core continue to be of great value to many Center affiliate investigators. The Core plans to continue to provide users with systematic and integrated approaches to the analysis of cell types that are critically involved in diabetes and its complications, obesity and related disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK017047-45
Application #
10077863
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2018-02-10
Project End
2022-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Mietlicki-Baase, Elizabeth G; Liberini, Claudia G; Workinger, Jayme L et al. (2018) A vitamin B12 conjugate of exendin-4 improves glucose tolerance without associated nausea or hypophagia in rodents. Diabetes Obes Metab 20:1223-1234
Gordon, Sharona E; Munari, Mika; Zagotta, William N (2018) Visualizing conformational dynamics of proteins in solution and at the cell membrane. Elife 7:
Olivo, Robert E; Davenport, Clemontina A; Diamantidis, Clarissa J et al. (2018) Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study. Nephrol Dial Transplant 33:992-1001
Uusitalo, Ulla; Lee, Hye-Seung; Andrén Aronsson, Carin et al. (2018) Early Infant Diet and Islet Autoimmunity in the TEDDY Study. Diabetes Care 41:522-530
Brault, Michelle; Olsen, Tayla M; Martinez, Jennifer et al. (2018) Intracellular Nucleic Acid Sensing Triggers Necroptosis through Synergistic Type I IFN and TNF Signaling. J Immunol 200:2748-2756
Hofsteen, Peter; Robitaille, Aaron Mark; Strash, Nicholas et al. (2018) ALPK2 Promotes Cardiogenesis in Zebrafish and Human Pluripotent Stem Cells. iScience 2:88-100
Hippe, Daniel S; Phan, Binh An P; Sun, Jie et al. (2018) Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/ Arterioscler Thromb Vasc Biol 38:673-678
Subramanian, Savitha; Goodspeed, Leela; Wang, Shari et al. (2018) Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr-/- Mice. Int J Mol Sci 19:
James, Eddie A; Pietropaolo, Massimo; Mamula, Mark J (2018) Immune Recognition of ?-Cells: Neoepitopes as Key Players in the Loss of Tolerance. Diabetes 67:1035-1042
Liese, Angela D; Ma, Xiaonan; Ma, Xiaoguang et al. (2018) Dietary quality and markers of inflammation: No association in youth with type 1 diabetes. J Diabetes Complications 32:179-184

Showing the most recent 10 out of 1296 publications